Cannabinoid Oral Care + antimicrobial

Cannabinoid Oral Care + antimicrobial is a preclinical-stage cannabinoid-based oral care composition developed by APIRx Pharmaceutical USA (subsequently acquired by Incannex Healthcare). The product is formulated for oral administration and is specifically intended to address oral infections and other antimicrobial applications. It utilizes cannabinoids as the active therapeutic ingredients, leveraging APIRx's proprietary technology for the sustained oral mucosal delivery of cannabinoid formulations. While the specific cannabinoid profile and secondary antimicrobial agents (if any) have not been publicly detailed, the candidate is designed to provide localized treatment within the oral cavity.

Other names

cannabinoid oral-care composition